|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/137 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61P 25/24 | (2006.01) |
| (11) | Number of the document | 3908270 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20737928.0 |
| Date of filing the European patent application | 2020-01-07 | |
| (97) | Date of publication of the European application | 2021-11-17 |
| (45) | Date of publication and mention of the grant of the patent | 2025-08-27 |
| (46) | Date of publication of the claims translation | 2025-12-10 |
| (86) | Number | PCT/US2020/012612 |
| Date | 2020-01-07 |
| (87) | Number | WO 2020/146412 |
| Date | 2020-07-16 |
| (30) | Number | Date | Country code |
| 201962789431 P | 2019-01-07 | US | |
| 201962789446 P | 2019-01-07 | US | |
| 201962789451 P | 2019-01-07 | US | |
| 201962789488 P | 2019-01-07 | US |
| (72) |
TABUTEAU, Herriot , US
|
| (73) |
Antecip Bioventures II LLC ,
630 Fifth Avenue, Suite 2000, New York, NY 10111,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Bupropiono ir dekstrometorfano derinys, skirtas azijiečių kilmės pacientų depresijos gydymui |
| COMBINATION OF DEXTROMETHORPHAN AND BUPROPION FOR TREATING DEPRESSION IN ASIAN PATIENTS |
| Payment date | Validity (years) | Amount | |
| 2026-02-10 | 7 | 243.00 EUR |
| 2027-01-07 |